Ahmed L. Alaofi
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems 3
- Advancements in Transdermal Drug Delivery 3
-
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 2
-
- Protein Structure and Dynamics 2
- RNA Interference and Gene Delivery 2
-
- Nail Diseases and Treatments 2
-
- Animal Virus Infections Studies 2
- Co-authors
- Mudassar ShahidNabil A. AlhakamyOsama A. A. AhmedUsama A. FahmyTeruna J. SiahaanMohammad RaishMushtaq Ahmad AnsariAbdul Ahad
- Partner nations
- Saudi ArabiaUnited StatesIndia
In The Last Decade
Ahmed L. Alaofi
24 papers receiving 378 citations
Peers
Comparison fields: 5 of 90
- Pharmaceutical Science 47
- Pharmacology 32
- Infectious Diseases 60
- Microbiology 18
- Complementary and alternative medicine 22
Countries citing papers authored by Ahmed L. Alaofi
This map shows the geographic impact of Ahmed L. Alaofi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed L. Alaofi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed L. Alaofi more than expected).
Fields of papers citing papers by Ahmed L. Alaofi
This network shows the impact of papers produced by Ahmed L. Alaofi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed L. Alaofi. The network helps show where Ahmed L. Alaofi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ahmed L. Alaofi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 33 | |
| 11 | 2021 | 15 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 28 | |
| 14 | 2020 | 7 | |
| 15 | 2020 | 34 | |
| 16 | 2020 | 82 | |
| 17 | 2020 | 6 | |
| 18 | 2020 | 8 | |
| 19 | 2019 | 18 | |
| 20 | 2016 | 26 |
About Ahmed L. Alaofi
Ahmed L. Alaofi is a scholar working on Pharmaceutical Science, Molecular Medicine and Infectious Diseases, having authored 25 papers that have together received 382 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Advanced Drug Delivery Systems (3 papers), Advancements in Transdermal Drug Delivery (3 papers), Protein Structure and Dynamics (2 papers), Nail Diseases and Treatments (2 papers), RNA Interference and Gene Delivery (2 papers), COVID-19 Clinical Research Studies (2 papers) and Animal Virus Infections Studies (2 papers). The work is most often cited by research in Pharmaceutical Science (47 citations), Pharmacology (32 citations) and Infectious Diseases (60 citations). Ahmed L. Alaofi has collaborated with scholars based in Saudi Arabia, United States and India. Frequent co-authors include Mudassar Shahid, Nabil A. Alhakamy, Osama A. A. Ahmed, Usama A. Fahmy, Teruna J. Siahaan, Mohammad Raish, Mushtaq Ahmad Ansari, Abdul Ahad, Yousef A. Bin Jardan and Khalid M. Alkharfy. Their work appears in journals such as International Journal of Pharmaceutics, Molecules, ACS Omega, Journal of Biomolecular Structure and Dynamics and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.